- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Board Meeting, 12-02-2026: Outcome of Board Meeting
12-02-2026 | 07:13 pm
12-02-2026 | 07:13 pm
Biocon's board approved Q3 & 9M consolidated financial results: revenue hit ₹4,173 Cr, profit at ₹143.8 Cr. Strategically, they approved acquiring the remaining ~2% of Biocon Biologics via a preferential share allotment, making it a wholly-owned subsidiary.
No comments yet. Be the first to comment!